Patrick A Singleton Selected Research

Patrick A Singleton Research Topics

Disease

17	Neoplasms (Cancer) 08/2015 - 10/2002
7	Lung Neoplasms (Lung Cancer) 01/2015 - 09/2009
7	Acute Lung Injury 07/2014 - 04/2009
7	Lung Injury 03/2012 - 10/2007
4	Neoplasm Metastasis (Metastasis) 01/2015 - 03/2011
4	Breast Neoplasms (Breast Cancer) 08/2010 - 10/2002
3	Ventilator-Induced Lung Injury 07/2014 - 04/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014 - 06/2010
3	Sepsis (Septicemia) 08/2011 - 04/2005
3	Pneumonia (Pneumonitis) 01/2011 - 12/2009
2	Hyperoxia 03/2012 - 12/2009
2	Pulmonary Hypertension 08/2011 - 04/2008
2	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 08/2010
1	COVID-19 04/2023
1	Opioid-Induced Constipation 08/2015
1	Chronic Pain 08/2015
1	Adenocarcinoma of Lung 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 04/2012
1	Lung Diseases (Lung Disease) 08/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2011
1	Asthma (Bronchial Asthma) 08/2011
1	Lewis Lung Carcinoma 03/2011
1	Vascular Diseases (Vascular Disease) 01/2011
1	Respiratory Insufficiency (Respiratory Failure) 01/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2010
1	Reperfusion Injury 12/2009

Drug/Important Bio-Agent (IBA)

9	Hyaluronic Acid (Hyaluronan)IBA 01/2015 - 10/2002
5	methylnaltrexone FDA Link 08/2015 - 06/2008
5	Opioid Analgesics (Opioids)IBA 08/2015 - 08/2010
5	Proteins (Proteins, Gene)FDA Link 07/2013 - 10/2002
4	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2015 - 06/2008
4	Small Interfering RNA (siRNA)IBA 01/2015 - 12/2009
4	Anesthetics (Anesthetic Agents)IBA 01/2014 - 08/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 12/2009
4	Opioid Receptors (Opioid Receptor)IBA 04/2012 - 08/2010
4	LipopolysaccharidesIBA 08/2011 - 10/2007
3	Carrier Proteins (Binding Protein)IBA 01/2014 - 01/2011
3	Caveolin 1IBA 11/2010 - 04/2009
2	Narcotic Antagonists (Opioid Antagonists)IBA 08/2015 - 03/2011
2	NestinIBA 01/2015 - 04/2012
2	Serine Proteases (Serine Protease)IBA 01/2015 - 04/2005
2	GlycosaminoglycansIBA 01/2015 - 08/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2014 - 12/2009
2	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 07/2014 - 04/2009
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2014 - 08/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 04/2008
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2012 - 10/2010
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2012 - 12/2009
2	Myosin-Light-Chain KinaseIBA 03/2012 - 01/2011
2	Tyrosine (L-Tyrosine)FDA Link 03/2012 - 12/2009
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2012 - 12/2009
2	Opiate AlkaloidsIBA 03/2011 - 08/2010
2	Phosphotransferases (Kinase)IBA 01/2011 - 10/2002
2	RNA (Ribonucleic Acid)IBA 01/2011 - 04/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 09/2009
2	TOR Serine-Threonine KinasesIBA 06/2010 - 02/2010
2	CytokinesIBA 05/2009 - 08/2003
2	rho-Associated KinasesIBA 06/2004 - 08/2003
1	SaltsIBA 04/2023
1	Hyaluronan ReceptorsIBA 01/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2015
1	EphrinsIBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 07/2014
1	Growth Factor ReceptorsIBA 01/2014
1	Apoptosis Regulatory ProteinsIBA 07/2013
1	PaxillinIBA 07/2013
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	Blood Proteins (Serum Proteins)IBA 11/2012
1	temsirolimus FDA Link 04/2012
1	CortactinIBA 03/2012
1	Cytoskeletal ProteinsIBA 03/2012
1	Superoxides (Superoxide)IBA 03/2012
1	EnzymesIBA 08/2011
1	AgarIBA 03/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	Protein Isoforms (Isoforms)IBA 01/2011
1	Liposomes (Liposome)IBA 01/2011
1	Sphingosine-1-Phosphate ReceptorsIBA 10/2010
1	SEW2871IBA 10/2010
1	SphingolipidsIBA 10/2010
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2010
1	Therapeutic UsesIBA 10/2010
1	Morphine (MS Contin)FDA LinkGeneric 08/2010
1	General AnestheticsIBA 08/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2010
1	MTOR InhibitorsIBA 02/2010
1	GTP Phosphohydrolases (GTPases)IBA 12/2009
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 12/2009

Therapy/Procedure

4	Mechanical Ventilators (Ventilator) 01/2011 - 05/2009
3	Therapeutics 08/2015 - 02/2010
2	Analgesia 08/2015 - 08/2010
2	Ligation 10/2010 - 04/2005
1	Perioperative Period 08/2015
1	Intravenous Injections 01/2011
1	Artificial Respiration (Mechanical Ventilation) 01/2011
1	Intravenous Administration 10/2010